Published in Infect Immun on July 01, 1988
A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J Clin Invest (1990) 3.03
Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice. Infect Immun (1997) 1.63
Role of CD4+ lymphocytes in resistance to mucosal candidiasis. Infect Immun (1991) 1.55
Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect Immun (1998) 1.32
Gamma interferon cooperates with lipopolysaccharide to activate mouse splenic macrophages to an antihistoplasma state. Infect Immun (1993) 1.29
Administration of purified anti-L3T4 monoclonal antibody impairs the resistance of mice to Listeria monocytogenes infection. Infect Immun (1989) 1.26
Antigenicity and immunogenicity of an extract from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun (1991) 1.21
Relative susceptibilities of inbred mouse strains C57BL/6 and A/J to infection with Histoplasma capsulatum. Infect Immun (1989) 1.21
Immunobiological activity of recombinant H antigen from Histoplasma capsulatum. Infect Immun (1995) 1.19
Protective efficacy of a 62-kilodalton antigen, HIS-62, from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun (1991) 1.19
CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with histoplasma capsulatum. J Exp Med (1998) 1.12
Vbeta4(+) T cells promote clearance of infection in murine pulmonary histoplasmosis. J Clin Invest (1998) 1.06
Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum. J Clin Invest (2005) 1.06
Prospects for the development of fungal vaccines. Clin Microbiol Rev (1997) 1.02
Cellular and molecular regulation of vaccination with heat shock protein 60 from Histoplasma capsulatum. Infect Immun (2002) 1.02
Protective immunity in murine histoplasmosis: functional comparison of adoptively transferred T-cell clones and splenic T cells. Infect Immun (1988) 0.99
Interleukin-1 and host control of pulmonary histoplasmosis. J Infect Dis (2006) 0.97
T cells require tumor necrosis factor-alpha to provide protective immunity in mice infected with Histoplasma capsulatum. J Infect Dis (2005) 0.95
Efficacy of nikkomycin Z in the treatment of murine histoplasmosis. Antimicrob Agents Chemother (1998) 0.95
Functional analysis of Histoplasma capsulatum-reactive T-cell hybridomas. Infect Immun (1990) 0.92
Recombinant murine granulocyte-macrophage colony-stimulating factor modulates the course of pulmonary histoplasmosis in immunocompetent and immunodeficient mice. Antimicrob Agents Chemother (2000) 0.91
Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice. Antimicrob Agents Chemother (2000) 0.90
Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes. Clin Diagn Lab Immunol (1994) 0.88
Transfer of protective immunity in murine histoplasmosis by a CD4+ T-cell clone. Infect Immun (1993) 0.86
Use of anti-CD4+ hybridoma cells to induce Pneumocystis carinii in mice. Infect Immun (1994) 0.82
MyD88-dependent signaling drives host survival and early cytokine production during Histoplasma capsulatum infection. Infect Immun (2015) 0.78
Pulmonary V beta 4+ T cells from Histoplasma capsulatum-infected mice respond to a homologue of Sec31 that confers a protective response. J Infect Dis (2006) 0.77
A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44
Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol (1986) 35.41
Immunization of dissociated spleen cell cultures from normal mice. J Exp Med (1967) 30.93
Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology (1968) 24.83
Functions of rat T-lymphocyte subsets isolated by means of monoclonal antibodies. Immunol Rev (1983) 3.70
Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J Immunol (1985) 3.47
Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon. Infect Immun (1987) 2.03
Inhibition of growth of Histoplasma capsulatum by lymphokine-stimulated macrophages. J Immunol (1984) 1.97
Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced interleukin-2 production in Schistosoma mansoni infection. Infect Immun (1986) 1.71
Species heterogeneity in macrophage expression of the CD4 antigen. J Exp Med (1987) 1.49
Effect of antilymphocyte serum on animals experimentally infected with Histoplasma capsulatum or Cryptococcus neoformans. J Bacteriol (1969) 1.48
Immunoregulatory responses in experimental disseminated histoplasmosis: lymphoid organ histopathology and serological studies. Infect Immun (1979) 1.36
Histoplasma capsulatum infection in nude mice. Infect Immun (1978) 1.31
Development and characterization of Histoplasma capsulatum-reactive murine T-cell lines and clones. Infect Immun (1986) 1.16
Immunoregulation in disseminated histoplasmosis: characterization of splenic suppressor cell populations. Cell Immunol (1981) 1.14
Significance of thymus-derived lymphocytes in immunity elicited by immunization with ribosomes or live yeast cells of Histoplasma capsulatum. J Infect Dis (1978) 1.04
Modulation of cellular immune responses in mice with disseminated histoplasmosis by recombinant interleukin-2. Infect Immun (1986) 1.03
Immunoregulation in disseminated murine histoplasmosis: disturbances in the production of interleukins 1 and 2. J Immunol (1985) 0.95
Incidence, description and functional assessment of isolated quadricuspid aortic valves. Am J Cardiol (1990) 4.33
Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages. J Exp Med (1987) 2.87
Studies of immune mechanisms in leprosy. 3. The role of cellular and humoral factors in impairment of the in vitro immune response. J Immunol (1971) 2.71
The use of the eating disorder examination with children: a pilot study. Int J Eat Disord (1996) 2.56
Pharmacodynamics of carbenicillin in hepatic and renal failure. Ann Intern Med (1970) 2.47
The evolution of immunosuppressive cell populations in experimental mycobacterial infection. J Immunol (1978) 2.19
Inactivation of gentamicin by penicillins in patients with renal failure. Antimicrob Agents Chemother (1976) 1.94
Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc Natl Acad Sci U S A (2009) 1.81
Blockade of endogenous TNF-alpha exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J Immunol (1998) 1.75
Nonoxynol-9 causes rapid exfoliation of sheets of rectal epithelium. Contraception (2000) 1.72
Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice. Infect Immun (1997) 1.63
Disturbance of the blood T:B lymphocyte ratio in lepromatous leprosy. Clinical and immunologic correlations. N Engl J Med (1973) 1.60
Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest (1990) 1.59
Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest (1994) 1.56
Complex requirements for nascent and memory immunity in pulmonary histoplasmosis. J Immunol (1999) 1.54
Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections. Antimicrob Agents Chemother (1987) 1.53
Regional cerebral blood flow following resuscitation from hemorrhagic shock with hypertonic saline. Influence of a subdural mass. Anesthesiology (1991) 1.47
Immunoregulatory responses in experimental disseminated histoplasmosis: depression of T-cell-dependent and T-effectory responses by activation of splenic suppressor cells. Infect Immun (1979) 1.45
Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infect Immun (1995) 1.44
Antiendotoxin monoclonal antibodies for gram-negative sepsis: guidelines from the IDSA. Clin Infect Dis (1992) 1.41
Defective leukotaxis in patients with lepromatous leprosy. J Lab Clin Med (1976) 1.41
Modulation of immune responses in murine pulmonary histoplasmosis. J Infect Dis (1997) 1.39
Cerebral blood flow decreases with time whereas cerebral oxygen consumption remains stable during hypothermic cardiopulmonary bypass in humans. Anesth Analg (1991) 1.39
Immunoregulatory responses in experimental disseminated histoplasmosis: lymphoid organ histopathology and serological studies. Infect Immun (1979) 1.36
Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect Immun (1998) 1.32
Aberrant immunoregulatory control of B lymphocyte function in lepromatous leprosy. Clin Exp Immunol (1982) 1.30
Failure of lymphocyte transformation in response to gamma-globulins in rheumatoid arthritis. Lancet (1969) 1.27
Anergy and infection. Adv Intern Med (1976) 1.27
Comparison of 22 species of Mycobacteria by immunodiffusion against an absorbed reference leprosy serum. Int J Lepr Other Mycobact Dis (1981) 1.26
Prospective study of alcohol-related admissions in an inner-city hospital. Lancet (1986) 1.25
Perturbation of lymphocyte circulation in experimental murine leprosy. II. Nature of the defect. J Immunol (1976) 1.24
Histoplasmosis. Association with circulating immune complexes, eosinophilia, and mesangiopathic glomerulonephritis. Arch Intern Med (1979) 1.24
Perturbation of lymphocyte circulation in experimental murine leprosy. I. Description of the defect. J Immunol (1976) 1.22
Antigenicity and immunogenicity of an extract from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun (1991) 1.21
An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy. N Engl J Med (1972) 1.20
Protective efficacy of a 62-kilodalton antigen, HIS-62, from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect Immun (1991) 1.19
Leprosy: a model of immunological perturbation in chronic infection. J Infect Dis (1978) 1.18
Development and characterization of Histoplasma capsulatum-reactive murine T-cell lines and clones. Infect Immun (1986) 1.16
Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages. Infect Immun (1991) 1.16
Immunoregulation in disseminated histoplasmosis: characterization of splenic suppressor cell populations. Cell Immunol (1981) 1.14
Utility of color flow imaging for visualizing shunt flow in atrial septal defect. Int J Cardiol (1989) 1.14
Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol (1990) 1.14
Changing incidence and etiology of iatrogenic ureteral injuries. J Urol (1994) 1.11
Simple assay for clindamycin in the presence of aminoglycosides. Antimicrob Agents Chemother (1974) 1.11
Can mannitol reduce amphotericin B nephrotoxicity? Double-blind study and description of a new vascular lesion in kidneys. Antimicrob Agents Chemother (1976) 1.11
Regulation of infection with Histoplasma capsulatum by TNFR1 and -2. J Immunol (2000) 1.10
Digestion of Histoplasma capsulatum yeasts by human macrophages. J Immunol (1992) 1.08
The pathogenesis of experimental pulmonary histoplasmosis. Correlative studies of histopathology, bronchoalveolar lavage, and respiratory function. Am Rev Respir Dis (1986) 1.07
A homoallelic Gly317-->Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian mennonites. Genomics (1993) 1.07
Carbenicillin therapy of Pseudomonas and other gram-negative bacillary infections. Ann Intern Med (1970) 1.06
An 80-kilodalton antigen from Histoplasma capsulatum that has homology to heat shock protein 70 induces cell-mediated immune responses and protection in mice. Infect Immun (1992) 1.06
Medical mycology in crisis. J Lab Clin Med (1983) 1.06
Vbeta4(+) T cells promote clearance of infection in murine pulmonary histoplasmosis. J Clin Invest (1998) 1.06
Histoplasma acquisition of calcium and expression of CBP1 during intracellular parasitism. Mol Microbiol (1998) 1.03
Modulation of cellular immune responses in mice with disseminated histoplasmosis by recombinant interleukin-2. Infect Immun (1986) 1.03
Molecular cloning, characterization, and expression of the M antigen of Histoplasma capsulatum. Infect Immun (1999) 1.02
Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid. Antimicrob Agents Chemother (1985) 0.99
Characterization of antigenic determinants in histoplasmin that stimulate Histoplasma capsulatum-reactive T cells in vitro. Infect Immun (1988) 0.98
The URA5 gene is necessary for histoplasma capsulatum growth during infection of mouse and human cells. Infect Immun (1999) 0.98
Chondromatous metaplasia in the human larynx. Histopathology (1980) 0.98
A research report on the anti-fatigue effects of magnesium pemoline. Psychopharmacologia (1968) 0.97
Cellular immune responses to recombinant heat shock protein 70 from Histoplasma capsulatum. Infect Immun (1996) 0.97
Stress proteins in fungal diseases. Med Mycol (1998) 0.97
FE(NO): relationship to exhalation rates and online versus bag collection in healthy adolescents. Am J Respir Crit Care Med (2000) 0.97
Age-related prevalence of valvular regurgitation in normal subjects: a comprehensive color flow examination of 118 volunteers. J Am Soc Echocardiogr (1990) 0.96
Clinical and pharmacological studies of ticarcillin in gram-negative infections. Antimicrob Agents Chemother (1976) 0.95
Blastogenic responses to Pneumocystis carinii among patients with human immunodeficiency (HIV) infection. Clin Exp Immunol (1988) 0.95
Immunoregulation in disseminated murine histoplasmosis: disturbances in the production of interleukins 1 and 2. J Immunol (1985) 0.95
Studies of immune mechanisms in leprosy. II Quantitative relationships of IgG, IgA, and IgM immunoglobulins. J Lab Clin Med (1970) 0.94
Development of vaccines and their use in the prevention of fungal infections. Med Mycol (1998) 0.94
V beta 6+ and V beta 4+ T cells exert cooperative activity in clearance of secondary infection with Histoplasma capsulatum. J Immunol (2001) 0.93
Quantitative and qualitative studies of the local cellular exudative response in leprosy. J Reticuloendothel Soc (1974) 0.93
Regional cerebrovascular responses to progressive hypotension after traumatic brain injury in cats. Am J Physiol (1992) 0.92
Reduced cerebral blood flow, oxygen delivery, and electroencephalographic activity after traumatic brain injury and mild hemorrhage in cats. J Neurosurg (1992) 0.92
Histoplasma capsulatum strain variation in both H antigen production and beta-glucosidase activity and overexpression of HAG1 from a telomeric linear plasmid. Infect Immun (1999) 0.90
Impairment of cell-mediated immune responses by infection with Mycobacterium lepraemurium. Infect Immun (1977) 0.90
Decreased suppressor cell activity in disseminated granulomatous infections. Clin Exp Immunol (1980) 0.90
Cellular origins and target cells of immunoregulatory factors in mice with disseminated histoplasmosis. J Immunol (1984) 0.90
Applying in vivo expression technology (IVET) to the fungal pathogen Histoplasma capsulatum. Microb Pathog (2000) 0.90
Fatal reaction to dapsone during treatment of leprosy. Ann Intern Med (1981) 0.90
Immunoregulation in experimental disseminated histoplasmosis: flow microfluorometry (FMF) studies of the Thy and Lyt phenotypes of T lymphocytes from infected mice. J Immunol (1983) 0.88
Molecular cloning, characterization and expression of the heat shock protein 60 gene from the human pathogenic fungus Paracoccidioides brasiliensis. Med Mycol (2001) 0.88
Immunohistologic alteration of skin and ultrastructural changes of glomerular basement membranes in leprosy. Am J Trop Med Hyg (1974) 0.88
A statistical approach to the polymorphonuclear leukocyte bactericidal assay. J Lab Clin Med (1973) 0.87
Immunoregulation in disseminated histoplasmosis: characterization of the surface phenotype of splenic suppressor T lymphocytes. Infect Immun (1982) 0.86
Progression of aortic stenosis in adults: new appraisal using Doppler echocardiography. Am Heart J (1990) 0.86
Transfer of protective immunity in murine histoplasmosis by a CD4+ T-cell clone. Infect Immun (1993) 0.86
Binding of S protein by Neisseria gonorrhoeae and potential role in invasion. J Clin Microbiol (1991) 0.86
Aortic dissection: review of value and limitations of two-dimensional echocardiography in a six-year experience. J Am Soc Echocardiogr (1990) 0.86
Long term propranolol treatment and changes in body weight after myocardial infarction. BMJ (1990) 0.86
Luteinizing hormone release from dissociated pituitary cells by dimerization of occupied LHRH receptors. Nature (1982) 0.85
Immunological aspects of fungal pathogenesis. Eur J Clin Microbiol Infect Dis (1990) 0.85
Unexplained fever in burn patients due to cytomegalovirus infection. JAMA (1982) 0.84
Fulminant wound infection with Aeromonas hydrophila. South Med J (1980) 0.83